Dark Light
-11%

Lorbrena 100Mg Tablet In Pakistan


Lorbrena 100Mg Tablet in Pakistan contains lorlatinib, a prescription kinase inhibitor used for adults with metastatic ALK-positive non-small cell lung cancer (NSCLC). The recommended standard dose is 100mg once daily, with dosage adjustments required in certain medical conditions.

 3,999  4,499

Lorbrena 100Mg Tablet In Pakistan

Lorbrena 100Mg Tablet contains lorlatinib, a targeted kinase inhibitor used in the treatment of adults with metastatic ALK-positive non-small cell lung cancer (NSCLC). Patient selection is based on confirmation of ALK positivity using an appropriate approved test.

Lorlatinib works by inhibiting abnormal ALK signaling that can contribute to the growth and spread of ALK-positive cancer cells. It is designed to reach the central nervous system and is used in the management of metastatic ALK-positive NSCLC, including disease involving the brain.

Key Features

  • Contains Lorlatinib 100mg
  • Targeted kinase inhibitor
  • Used for metastatic ALK-positive NSCLC
  • Prescription-only cancer medicine
  • Oral tablet formulation
  • Standard recommended dose is 100mg once daily for appropriate patients

How to Take

The recommended dose is 100mg orally once daily, with or without food, unless your oncologist recommends a different dose. Swallow the tablet whole; do not chew, crush or split it. If you miss a dose, follow the prescribing instructions rather than taking two doses together.

Important Safety Information

Lorbrena is a prescription medicine and should only be used under the supervision of an oncologist or qualified healthcare professional. Important risks include central nervous system effects, changes in cholesterol and triglycerides, high blood pressure, high blood sugar, heart conduction abnormalities and interstitial lung disease/pneumonitis.

Lorlatinib can also interact with other medicines, including certain CYP3A-inducing or inhibiting drugs. Tell your doctor about all medicines and supplements you take before starting treatment. Dose adjustments may be necessary for some patients with liver or kidney impairment.

Why Choose Lorbrena 100Mg Tablet?

Lorbrena provides targeted therapy with lorlatinib for eligible patients whose metastatic NSCLC is ALK-positive. Because this is a specialized cancer medicine, treatment should be initiated and monitored by an experienced healthcare professional.

Category:

Lorbrena 100Mg Tablet in Pakistan contains lorlatinib, a prescription kinase inhibitor used for adults with metastatic ALK-positive non-small cell lung cancer (NSCLC). The recommended standard dose is 100mg once daily, with dosage adjustments required in certain medical conditions.

Based on 0 reviews

0.0 overall
0
0
0
0
0

Only logged in customers who have purchased this product may leave a review.

There are no reviews yet.